Stuiver Martijn M, ten Tusscher Marieke R, Agasi-Idenburg Carla S, Lucas Cees, Aaronson Neil K, Bossuyt Patrick M M
Department of Physiotherapy, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, Amsterdam, Netherlands, 1066CX.
Cochrane Database Syst Rev. 2015 Feb 13;2015(2):CD009765. doi: 10.1002/14651858.CD009765.pub2.
Breast cancer-related lymphoedema can be a debilitating long-term sequela of breast cancer treatment. Several studies have investigated the effectiveness of different treatment strategies to reduce the risk of breast cancer-related lymphoedema.
To assess the effects of conservative (non-surgical and non-pharmacological) interventions for preventing clinically-detectable upper-limb lymphoedema after breast cancer treatment.
We searched the Cochrane Breast Cancer Group's (CBCG) Specialised Register, CENTRAL, MEDLINE, EMBASE, CINAHL, PEDro, PsycINFO, and the World Health Organization (WHO) International Clinical Trials Registry Platform in May 2013. Reference lists of included trials and other systematic reviews were searched.
Randomised controlled trials that reported lymphoedema as the primary outcome and compared any conservative intervention to either no intervention or to another conservative intervention.
Three authors independently assessed the risk of bias and extracted data. Outcome measures included lymphoedema, infection, range of motion of the shoulder, pain, psychosocial morbidity, level of functioning in activities of daily life (ADL), and health-related quality of life (HRQoL). Where possible, meta-analyses were performed. Risk ratio (RRs) or hazard ratio (HRs) were reported for dichotomous outcomes or lymphoedema incidence, and mean differences (MDs) for range of motion and patient-reported outcomes.
Ten trials involving 1205 participants were included. The duration of patient follow-up ranged from 2 days to 2 years after the intervention. Overall, the quality of the evidence generated by these trials was low, due to risk of bias in the included trials and inconsistency in the results. Manual lymph drainageIn total, four studies used manual lymph drainage (MLD) in combination with usual care or other interventions. In one study, lymphoedema incidence was lower in patients receiving MLD and usual care (consisting of standard education or exercise, or both) compared to usual care alone. A second study reported no difference in lymphoedema incidence when MLD was combined with physiotherapy and education compared to physiotherapy alone. Two other studies combining MLD with compression and scar massage or exercise observed a reduction in lymphoedema incidence compared to education only, although this was not significant in one of the studies. Two out of the four studies reported on shoulder mobility where MLD combined with exercise gave better shoulder mobility for lateral arm movement (shoulder abduction) and forward flexion in the first weeks after breast cancer surgery, compared to education only (mean difference for abduction 22°; 95% confidence interval (CI) 14 to 30; mean difference for forward flexion 14°; 95% CI 7 to 22). Two of the studies on MLD reported on pain, with inconsistent results. Results on HRQoL in two studies on MLD were also contradictory. Exercise: early versus delayed start of shoulder mobilising exercisesThree studies examined early versus late start of postoperative shoulder exercises. The pooled relative risk of lymphoedema after an early start of exercises was 1.69 (95% CI 0.94 to 3.01, 3 studies, 378 participants). Shoulder forward flexion was better at one and six months follow-up for participants who started early with mobilisation exercises compared to a delayed start (two studies), but no meta-analysis could be performed due to statistical heterogeneity. There was no difference in shoulder mobility or self-reported shoulder disability at 12 months follow-up (one study). One study evaluated HRQoL and reported difference at one year follow-up (mean difference 1.6 points, 95% CI -2.14 to 5.34, on the Trial Outcome Index of the FACT-B). Two studies collected data on wound drainage volumes and only one study reported higher wound drainage volumes in the early exercise group. Exercise: resistance trainingTwo studies compared progressive resistance training to restricted activity. Resistance training after breast cancer treatment did not increase the risk of developing lymphoedema (RR 0.58; 95% CI 0.30 to 1.13, two studies, 358 participants) provided that symptoms are monitored and treated immediately if they occur. One out of the two studies measured pain where participants in the resistance training group reported pain more often at three months and six months compared to the control group. One study reported HRQoL and found no significant difference between the groups. Patient education, monitoring and early interventionOne study investigated the effects of a comprehensive outpatient follow-up programme, consisting of patient education, exercise, monitoring of lymphoedema symptoms and early intervention for lymphoedema, compared to education alone. Lymphoedema incidence was lower in the comprehensive outpatient follow-up programme (at any time point) compared to education alone (65 people). Participants in the outpatient follow-up programme had a significantly faster recovery of shoulder abduction compared to the education alone group.
AUTHORS' CONCLUSIONS: Based on the current available evidence, we cannot draw firm conclusions about the effectiveness of interventions containing MLD. The evidence does not indicate a higher risk of lymphoedema when starting shoulder-mobilising exercises early after surgery compared to a delayed start (i.e. seven days after surgery). Shoulder mobility (that is, lateral arm movements and forward flexion) is better in the short term when starting shoulder exercises earlier compared to later. The evidence suggests that progressive resistance exercise therapy does not increase the risk of developing lymphoedema, provided that symptoms are closely monitored and adequately treated if they occur.Given the degree of heterogeneity encountered, limited precision, and the risk of bias across the included studies, the results of this review should be interpreted with caution.
乳腺癌相关淋巴水肿可能是乳腺癌治疗导致的一种使人衰弱的长期后遗症。多项研究调查了不同治疗策略降低乳腺癌相关淋巴水肿风险的有效性。
评估保守(非手术和非药物)干预措施对预防乳腺癌治疗后临床上可检测到的上肢淋巴水肿的效果。
我们于2013年5月检索了Cochrane乳腺癌协作组(CBCG)专业注册库、Cochrane系统评价数据库、MEDLINE、EMBASE、CINAHL、PEDro、PsycINFO以及世界卫生组织(WHO)国际临床试验注册平台。对纳入试验的参考文献列表及其他系统评价进行了检索。
将淋巴水肿作为主要结局报告,并比较任何保守干预措施与不干预或与另一种保守干预措施的随机对照试验。
三位作者独立评估偏倚风险并提取数据。结局指标包括淋巴水肿、感染、肩部活动范围、疼痛、心理社会发病率、日常生活活动(ADL)功能水平以及健康相关生活质量(HRQoL)。在可能的情况下进行了Meta分析。对于二分结局或淋巴水肿发病率报告风险比(RRs)或风险比(HRs),对于活动范围和患者报告结局报告平均差(MDs)。
纳入了10项试验,涉及1205名参与者。干预后患者随访时间从2天到2年不等。总体而言,由于纳入试验存在偏倚风险且结果不一致,这些试验所产生证据的质量较低。
总共有四项研究将手法淋巴引流(MLD)与常规护理或其他干预措施联合使用。在一项研究中,与单独常规护理相比,接受MLD和常规护理(包括标准教育或运动,或两者兼有)的患者淋巴水肿发病率较低。第二项研究报告称,与单独物理治疗相比,MLD联合物理治疗和教育时淋巴水肿发病率无差异。另外两项将MLD与加压和瘢痕按摩或运动联合使用的研究发现,与仅教育相比,淋巴水肿发病率有所降低,尽管其中一项研究中这一结果并不显著。四项研究中有两项报告了肩部活动度,其中MLD联合运动在乳腺癌手术后的最初几周内,与仅教育相比,在侧臂运动(肩部外展)和前屈方面肩部活动度更好(外展平均差22°;95%置信区间(CI)14至30;前屈平均差14°;95%CI 7至22)。关于MLD的两项研究报告了疼痛情况,结果不一致。关于MLD的两项研究中HRQoL的结果也相互矛盾。
早期与延迟开始肩部活动锻炼:三项研究比较了术后肩部锻炼的早期开始与延迟开始。早期开始锻炼后淋巴水肿的合并相对风险为1.69(95%CI 0.94至3.01,3项研究,378名参与者)。与延迟开始相比,早期开始活动锻炼的参与者在随访1个月和6个月时肩部前屈情况更好(两项研究),但由于统计异质性无法进行Meta分析。在随访12个月时肩部活动度或自我报告的肩部残疾情况无差异(一项研究)。一项研究评估了HRQoL并报告在随访1年时有差异(在FACT - B试验结局指数上平均差1.6分,95%CI - 2.14至5.34)。两项研究收集了伤口引流量数据,只有一项研究报告早期锻炼组伤口引流量更高。
阻力训练:两项研究将渐进性阻力训练与限制活动进行了比较。乳腺癌治疗后进行阻力训练不会增加发生淋巴水肿的风险(RR 0.58;95%CI 0.30至1.13,两项研究,358名参与者),前提是对症状进行监测并在出现症状时立即进行治疗。两项研究中有一项测量了疼痛,其中阻力训练组参与者在3个月和6个月时报告疼痛的频率高于对照组。一项研究报告了HRQoL,发现两组之间无显著差异。
患者教育、监测和早期干预:一项研究调查了综合门诊随访计划的效果,该计划包括患者教育、运动、淋巴水肿症状监测和淋巴水肿早期干预,并与仅教育进行了比较。与仅教育相比,综合门诊随访计划(在任何时间点)的淋巴水肿发病率更低(65人)。门诊随访计划的参与者与仅教育组相比,肩部外展恢复明显更快。
基于目前可得的证据,我们无法就包含MLD的干预措施的有效性得出确凿结论。证据并未表明与延迟开始(即术后7天)相比,术后早期开始肩部活动锻炼会有更高的淋巴水肿风险。与延迟开始相比,早期开始肩部锻炼在短期内肩部活动度(即侧臂运动和前屈)更好。证据表明,渐进性阻力运动疗法不会增加发生淋巴水肿的风险,前提是对症状进行密切监测并在出现症状时进行充分治疗。鉴于所遇到的异质性程度、有限的精确性以及纳入研究中的偏倚风险,本综述的结果应谨慎解读。